Livongo Health (NASDAQ:LVGO) Short Interest Up 13.0% in October

Livongo Health (NASDAQ:LVGO) saw a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 5,140,000 shares, an increase of 13.0% from the September 30th total of 4,550,000 shares. Based on an average daily volume of 1,120,000 shares, the days-to-cover ratio is presently 4.6 days. Currently, 14.2% of the company’s stock are short sold.

A number of research analysts have recently commented on the company. Svb Leerink assumed coverage on Livongo Health in a research note on Monday, August 19th. They issued an “outperform” rating and a $50.00 target price for the company. Goldman Sachs Group began coverage on Livongo Health in a research report on Monday, August 19th. They set a “buy” rating and a $43.00 price objective for the company. Canaccord Genuity began coverage on Livongo Health in a research report on Monday, August 19th. They set a “buy” rating and a $46.00 price objective for the company. JPMorgan Chase & Co. began coverage on Livongo Health in a research report on Monday, August 19th. They set an “overweight” rating and a $43.00 price objective for the company. Finally, Morgan Stanley raised Livongo Health from an “equal weight” rating to an “overweight” rating and set a $42.00 price objective for the company in a research report on Wednesday, August 28th. Two equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Livongo Health currently has an average rating of “Buy” and an average price target of $44.30.

LVGO stock traded up $0.19 on Friday, reaching $25.55. 436,000 shares of the company traded hands, compared to its average volume of 920,905. The firm’s fifty day simple moving average is $20.64. Livongo Health has a one year low of $15.12 and a one year high of $45.68.

Livongo Health (NASDAQ:LVGO) last released its earnings results on Wednesday, November 6th. The company reported ($0.05) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.28) by $0.23. The company had revenue of $46.70 million for the quarter, compared to the consensus estimate of $42.77 million. Livongo Health had a negative return on equity of 119.92% and a negative net margin of 43.59%. Livongo Health’s quarterly revenue was up 148.7% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.55) earnings per share. On average, equities research analysts predict that Livongo Health will post -1.38 earnings per share for the current year.

Several institutional investors have recently made changes to their positions in the company. Rhumbline Advisers purchased a new position in shares of Livongo Health in the third quarter valued at about $238,000. Dean Capital Investments Management LLC bought a new stake in shares of Livongo Health in the third quarter worth about $275,000. Pembroke Management LTD bought a new stake in shares of Livongo Health in the third quarter worth about $1,128,000. Emerald Mutual Fund Advisers Trust bought a new stake in shares of Livongo Health in the third quarter worth about $1,292,000. Finally, Emerald Advisers LLC bought a new stake in shares of Livongo Health in the third quarter worth about $1,342,000. Institutional investors and hedge funds own 0.28% of the company’s stock.

About Livongo Health

Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.

Further Reading: What are the components of an earnings report?

Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.